Back to search results

TeKnO T1D e-Learning for School Nurses

This study is testing an e-Learning program called TeKnO T1D: School Intervention. This program is designed for school nurses to help them learn more about continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems used by students with type 1 diabetes (T1D). The goal is to see if this online curriculum can improve nurses' knowledge and confidence in using these devices. We are looking for certified school nurses in Pennsylvania who are currently caring for at least one student under 14 years old with T1D who uses a diabetes device. The study will measure how many nurses enroll, complete the 16-week curriculum, and stay in the study.

Study design
This is an interventional study planning to enroll 86 participants. It will evaluate the TeKnO T1D curriculum.
What's involved
Participants will complete pre- and post-surveys around a 16-week e-Learning curriculum.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoints for curriculum completion and retention are measured at the completion of the 16-week curriculum.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07482488

Technology Knowledge Optimization for Type 1 Diabetes in Schools

Not Yet Recruiting
NAAges 5+InterventionalHealth services
University of Pittsburgh
~86 participants
Updated 2026-03-19 on ClinicalTrials.gov
What's tested:TeKnO T1D curriculum

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Study Enrollment
Measured over Baseline
+5 more outcomes measured

Conditions

Type 1 Diabetes (T1D)

Explore related trials

Type 1 Diabetes Mellitus

Where it's being run

1 sites across 1 states
Pennsylvania1

Study leadership

  • Christine A March, MD, MS · PRINCIPAL_INVESTIGATOR · University of Pittsburgh
  • Seema Meighan, MSN, MPH, DNP · PRINCIPAL_INVESTIGATOR · Children's Hospital of Philadelphia

Who to contact

Clinical Research Coordinator
[email protected]
412-692-5797
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Certified school nurse or obtaining certification
Actively managing at least 1 student with type 1 diabetes ≤14 years of age who uses a diabetes device (CGM, insulin pump, or automated insulin delivery system)
Employed in a school district in PA
Equipped with a smartphone or device compatible with the app used to deliver curriculum
Parent of a child diagnosed with T1D for ≥6 months
Child ≤14 years of age and attends in-person school in Pennsylvania
Child uses a CGM and/or AID system

Exclusion

Not able to participate in English (all)
For School Nurses: No current work with in-person students (e.g., retired, cyber school only), not clinical school staff, prior participation in the study

What this trial measures

  • Study EnrollmentBaseline

    The percentage of eligible participants (school nurses) who consent to participate among those approached.

  • Curriculum completionPrimary endpoint (completion of 16 week curriculum)

    The percentage of enrolled participants who complete the TeKnO T1D: School curriculum

  • RetentionPrimary endpoint (completion of 16 week curriculum)

    The percent of enrolled participants who complete all study procedures.

  • Feasibility of Intervention MeasurePrimary endpoint (completion of 16 week curriculum)

    Feasibility will be measured using the Feasibility of Intervention Measure. This scale includes 4 items on a 1-5 Likert-type response scale with higher scores indicating greater feasibility. The scale score is an average of the 4 items (range 1-5). There are no subscales.

  • AcceptabilityPrimary endpoint (completion of 16 week curriculum)

    Acceptability will be measured using the Acceptability of Intervention Measure. This scale includes 4 items on a 1-5 Likert-type response scale with higher scores indicating greater acceptability. The scale score is an average of the 4 items (range 1-5). There are no subscales.

  • AppropriatenessPrimary endpoint (completion 16 week curriculum)

    Appropriateness will be measured using the Intervention Appropriateness Measure. This scale includes 4 items on a 1-5 Likert-type response scale with higher scores indicating greater appropriateness. The scale score is an average of the 4 items (range 1-5). There are no subscales.